Phase 3 Readout~month

Phase 3 Topline: A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Dos

Indication
Muscular Dystrophy, Duchenne

Other upcoming events for SRPT

Patent ExpiryPatent/Exclusivity Expiry: VYONDYS 53
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therap
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficac
Patent ExpiryPatent/Exclusivity Expiry: AMONDYS 45
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Dos — SRPT Phase 3 Readout | BioSniper